World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments
World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments
RELEASE DATE
07-Oct-2003
07-Oct-2003
REGION
Global
Global
Research Code: 4084-01-00-00-00
SKU: HC00080-GL-MR_02808
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC00080-GL-MR_02808
Description
Managing the drug discovery process and technologies has become one of the top challenges faced by the global pharma industry in the recent past; herein lies the opportunity for a spate of companies focusing on contract research in drug discovery. This report presents the opportunities in the top ten segments, where basic research/drug discovery is outsourced globally. The segments covered include outsourcing of research in oncology, central nervous system, autoimmune/inflammation, cardiovascular, infectious diseases, broad-based screening, chemistry, genomic targets, metabolism, and gene therapy.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Introduction
- Scope of Report
Challenges
- Challenges
- Establishing Credibility
- Developing Strategic Fit between Outsourcers and CRO
- Moving up the Value Chain
Drivers
- Market Drivers
- Global R&D Productivity
- Cost Advantages Leading to Growth in Outsourcing
- Increase in Time and Labor Intensive R&D Processes
Restraints
- Market Restraints
- Lack of Strong IPR Protection
- Lack of Domain Expertise Limiting CR Opportunities
- Unavailability of World-Class Infrastructure and Manpower
Oncology
Central Nervous System (CNS)
Autoimmune/Inflammation
Cardiovascular (CVS)
- Overview
- AMGEN
- Pfizer
- GlaxoSmithKline
- Hoffmann-La Roche
- Johnson & Johnson
Infectious Diseases
- Overview
- Amgen
- GlaxoSmithKline
- Taisho Pharmaceuticals
- Eli Lilly
- Novartis AG
Broad-based Screening
- Overview
- Eli Lilly
- Suntory Pharmaceutical
- Procter & Gamble
- Encysive Pharmaceuticals
- Novartis AG
Chemistry
- Overview
- Schering-Plough Corporation
- Bayer AG
- GlaxoSmithKline
- Eli Lilly
- Chiron Corporation
Genomic Targets
- Overview
- Pfizer
- Hoffmann-La Roche
- GlaxoSmithKline
- Abbott Laboratories
- Immuno-Designed Molecules SA
Metabolism
- Overview
- Pfizer
- Procter & Gamble
- Eli Lilly
- Merck & Co
- Novartis AG
Gene Therapy
- Overview
- Novartis AG
- Aventis Pharmaceuticals
- Eli Lilly
- Bayer AG
- Pfizer
Analysis
Market Trends
Entry Strategies
Growth Strategies
Related Research
Popular Topics
Managing the drug discovery process and technologies has become one of the top challenges faced by the global pharma industry in the recent past; herein lies the opportunity for a spate of companies focusing on contract research in drug discovery. This report presents the opportunities in the top ten segments, where basic research/drug discovery is outsourced globally. The segments covered include outsourcing of research in oncology, central nervous system, autoimmune/inflammation, cardiovascular, infectious diseases, broad-based screening, chemistry, genomic targets, metabolism, and gene therapy.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 4084-01-00-00-00 |
Is Prebook | No |